Roche gets oncology boost with cancer vaccine
May 16, 2014Research and Development, Sales and Marketing ASCO, Roche, bladder cancer, oncology
Roche’s most advanced experimental cancer immunotherapy has had impressive results in a small Phase I trial, reducing tumour size in …
Giotrif increases lung cancer survival
May 16, 2014Research and Development, Sales and Marketing Boehringer, Iressa, Roche, Tarceva, afatinib, giotrif, lung cancer
Boehringer Ingelheim is trumpeting overall survival results from a new analysis of two late-stage studies involving Giotrif in lung cancer …
AstraZeneca lung cancer data reveals promise
May 15, 2014Sales and Marketing ASCO, AstraZeneca, NSCLC, azd0291, lung cancer
AstraZeneca has released promising data in a lung cancer trial with one of its investigational drugs, AZD9291, which has breakthrough …
Scrap ‘iniquitous and outdated’ NHS prescription charges
May 15, 2014Sales and Marketing BMJ, NHS, charges, dab, drugs, prescription
The NHS prescription charge is iniquitous and outdated and needs to be scrapped, according to an editorial in the Drug …
K-V Pharmaceutical hires head of women’s healthcare
May 15, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing KV, paul williams
K-V Pharmaceutical (KV) has hired industry veteran and former Actavis head Paul Williams to lead its women’s healthcare division. Williams …
MedImmune signs Incyte oncology deal
May 15, 2014Research and Development, Sales and Marketing AstraZeneca, Cancer, Incyte, MedImmune, oncology
MedImmune, the global biologics R&D arm of AstraZeneca, is to put one of its oncology immunotherapies into development in combination …
Pfizer: ‘fewer scientists’ after merger
May 14, 2014Research and Development, Sales and Marketing AstraZeneca, Pfizer, Read, Soriot, UK, Willetts, merger, takeover
Pfizer’s proposed takeover of AstraZeneca would result in there being fewer scientists from both companies in the UK than currently …
More late-stage anguish for GSK heart drug
May 14, 2014Research and Development, Sales and Marketing GSK, Patrick Vallance, darapladib, heart
GlaxoSmithKline’s experimental heart drug darapladib has failed to meet its primary endpoint in a Phase III trial for the second …
GSK China head arrested over bribery charges
May 14, 2014Medical Communications, Sales and Marketing China, GSK, bribery, pharma, reilly
A British man who headed-up GlaxoSmithKline’s troubled China business has been charged with two other executives on charges of bribery …
Pfizer grilled by MPs – but AZ revelations shock
May 14, 2014Medical Communications, Sales and Marketing AZ, Pfizer, committee, merger, takeover
The two chiefs of AstraZeneca and Pfizer went head-to-head with MPs yesterday fighting their own corners in what is an …
Just:: appoints digital specialist
May 14, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Daniel Prideaux, Just, Just::, digital
Just:: Health Communications has hired Daniel Prideaux to head-up its digital offering. Prideaux joins from DigitasLBi and previously worked at …
NICE: no early Zytiga use
May 14, 2014Sales and Marketing Cancer, Janssen, NHS, NICE, Zytiga, johnson, prostate
Janssen has criticised NICE’s decision not to recommend Zytiga on the NHS at an earlier stage in the prostate cancer …
Toshiba creates disease diagnosis tool
May 13, 2014Medical Communications, Research and Development, Sales and Marketing Disease, Japan, breath analyser, toshiba
Japan’s multinational electronics firm Toshiba has developed a breath-analysing prototype system that it says can be used to diagnose diseases. …
Teva considers up to 27 plant closures
May 13, 2014Manufacturing and Production, Sales and Marketing Copaxone, Nerventra, Teva, cuts, generics
Teva is to close 11 of its production sites, with another 16 facilities ‘under evaluation’, as part of a major …
Valeant ‘substantially undervalues’ Allergan
May 13, 2014Sales and Marketing Allergan, Botox, Pfizer, Valeant, buyout, merger
Allergan’s board has issued a defiant, unanimous rejection of the multi-billion dollar takeover offer made public by Valeant last month. In …
Ranbaxy woes hit profits
May 13, 2014Manufacturing and Production, Sales and Marketing Q1, Ranbaxy, Sun Pharma, manufacturing, recall
Indian generics maker Ranbaxy Laboratories has slipped up in the first quarter of the year, with profit sliding to 0.3 …
Biotec hires non-executive director
May 13, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biotec, ashley cooper
Logistics services firm Biotec Services International has expanded its board with the appointment of a non-executive director. Joining the UK-headquartered …
Poll: UK opposed to Pfizer takeover bid of AZ
May 13, 2014Research and Development, Sales and Marketing AstraZeneca, Cameron, Pfizer, UK, buyout, merger, research
The UK’s largest union says a new poll shows that the vast majority of the British public are against Pfizer’s …
SHL to attend the 2014 PDA Japan: A collaborative approach to developing combination products
May 13, 2014Medical Communications auto injector, autoinjectors, pda japan 2014, pen injector, shl pda 2014
Tokyo, Japan – SHL, the world’s largest privately-owned designer, developer and manufacturer of advanced drug delivery devices, announced today that …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
